🚀🙌 We are thrilled to acknowledge and extend our heartfelt praise to the incredible speakers whose insights made the first day of 73rd IPC Hyderabad 2024 an extraordinary experience. Their expertise and vision set the tone for a truly enlightening conference. 🚀
👨🏫 Anant Paradkar: Enlightened us with his deep dive into sustainable manufacturing and packaging innovations, offering a roadmap for a greener future.
👨🏫 Michael Coleman: Astonished everyone with his groundbreaking work on a membrane-based vaccine for head and neck cancer, promising a new frontier in cancer treatment.
👩⚕️ Alka Mukne: Unveiled the transformative potential of AI in Healthcare 5.0, showcasing revolutionary advancements in patient care.
👨⚕️Kamlesh Soni, PhD: Highlighted the vast global opportunities available for Indian pharmacists, inspiring us to think beyond borders.
👨🏫 Sohan Chitlange: Empowered the next generation of pharma professionals with his focus on education and training, ensuring a bright future for our industry.
👩⚕️ Rajni Jha: Addressed the critical challenges in regulatory and quality compliance, providing practical solutions and insights.
👨🔬 Sandip B. Bharate: Explored cutting-edge advancements in natural products-driven medicinal chemistry, paving the way for innovative drug discovery.
▶ Our Pharma Now team had an enriching experience, engaging with these leading experts and gaining invaluable insights. The sessions provided fresh perspectives and sparked meaningful discussions, enhancing the audience’s understanding of the latest industry trends. 🙌 We are confident that the attendees will be excited to bring this knowledge back to their work and continue fostering innovation in the pharmaceutical field. 🤩
💬 Join the Conversation! Comment down if you were part of any of the sessions on Day 1. Which session resonated with you the most? Share your thoughts below! 📥
👀 Stay tuned for more updates and exclusive content from IPC 2024!
#PharmaNow #IPC2024 #PharmaIndustry #HealthcareInnovation #Networking #StayTuned #73IPC2024Hyderabad